Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sawai Pharmaceutical Co Ltd (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11529
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company’s products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution, and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.

Sawai Pharmaceutical Co Ltd (4555) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Partnerships 14
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Equity Offering 21
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Asset Transactions 22
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Acquisition 24
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million 28
Sawai Pharmaceutical Co Ltd – Key Competitors 30
Sawai Pharmaceutical Co Ltd – Key Employees 31
Sawai Pharmaceutical Co Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Corporate Communications 33
May 15, 2018: Sawai Pharmaceutical Announce Personnel Changes 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million 28
Sawai Pharmaceutical Co Ltd, Key Competitors 30
Sawai Pharmaceutical Co Ltd, Key Employees 31
Sawai Pharmaceutical Co Ltd, Subsidiaries 32

List of Figures
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telenet Group Holding NV (TNET):企業の財務・戦略的SWOT分析
    Telenet Group Holding NV (TNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Diebold Nixdorf, Incorporated:企業の戦略・SWOT・財務情報
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Emerald Resources NL (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • NCC Group plc:企業の戦略・SWOT・財務分析
    NCC Group plc - Strategy, SWOT and Corporate Finance Report Summary NCC Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • GN Store Nord AS (GN):企業の財務・戦略的SWOT分析
    GN Store Nord AS (GN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Leonardo DRS Inc:企業の戦略的SWOT分析
    Leonardo DRS Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Valensa International LLC:企業の戦略・SWOT・財務情報
    Valensa International LLC - Strategy, SWOT and Corporate Finance Report Summary Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Schindler Holding Ltd.:戦略・SWOT・企業財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Jones Financial Companies, L.L.L.P.:企業の戦略的SWOT分析
    The Jones Financial Companies, L.L.L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • OPKO Health Inc (OPK):製薬・医療:M&Aディール及び事業提携情報
    Summary OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vac …
  • Brookfield Infrastructure Partners LP:企業のM&A・事業提携・投資動向
    Brookfield Infrastructure Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brookfield Infrastructure Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Systematic A/S:企業の戦略・SWOT・財務情報
    Systematic A/S - Strategy, SWOT and Corporate Finance Report Summary Systematic A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Booz Allen Hamilton Holding Corporation (BAH):企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corporation (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …
  • Pharmacosmos AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Travere Therapeutics Inc (TVTX):企業の財務・戦略的SWOT分析
    Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bioactive Bone Substitutes Ltd:製品パイプライン分析
    Summary Bioactive Bone Substitutes Ltd (BBS) is a manufacturer of biologically active medical device implants for orthopedic surgery. The company offers technology platforms, artebone, research and development, and patents. Its artebone is made up of an animal source of bone material used for bone r …
  • Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析
    Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, micr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆